ID   EHD2_MOUSE              Reviewed;         543 AA.
AC   Q8BH64; Q8BL28;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   07-APR-2021, entry version 166.
DE   RecName: Full=EH domain-containing protein 2 {ECO:0000305};
GN   Name=Ehd2 {ECO:0000312|MGI:MGI:2154274};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH EHBP1, SUBCELLULAR
RP   LOCATION, IDENTIFICATION BY MASS SPECTROMETRY, TISSUE SPECIFICITY, AND
RP   DOMAIN.
RC   STRAIN=C57BL/6J;
RX   PubMed=14676205; DOI=10.1074/jbc.m307702200;
RA   Guilherme A., Soriano N.A., Bose S., Holik J., Bose A., Pomerleau D.P.,
RA   Furcinitti P., Leszyk J., Corvera S., Czech M.P.;
RT   "EHD2 and the novel EH domain binding protein EHBP1 couple endocytosis to
RT   the actin cytoskeleton.";
RL   J. Biol. Chem. 279:10593-10605(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J;
RC   TISSUE=Adipose tissue, Embryonic eye, Embryonic head, Embryonic lung,
RC   Forelimb, and Liver;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-438, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic brain;
RX   PubMed=15345747; DOI=10.1074/mcp.m400085-mcp200;
RA   Ballif B.A., Villen J., Beausoleil S.A., Schwartz D., Gygi S.P.;
RT   "Phosphoproteomic analysis of the developing mouse brain.";
RL   Mol. Cell. Proteomics 3:1093-1101(2004).
RN   [5]
RP   FUNCTION, INTERACTION WITH MYOF, MUTAGENESIS OF GLY-65, IDENTIFICATION BY
RP   MASS SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=18502764; DOI=10.1074/jbc.m802306200;
RA   Doherty K.R., Demonbreun A.R., Wallace G.Q., Cave A., Posey A.D.,
RA   Heretis K., Pytel P., McNally E.M.;
RT   "The endocytic recycling protein EHD2 interacts with myoferlin to regulate
RT   myoblast fusion.";
RL   J. Biol. Chem. 283:20252-20260(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-438, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=19131326; DOI=10.1074/mcp.m800451-mcp200;
RA   Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.;
RT   "Large scale localization of protein phosphorylation by use of electron
RT   capture dissociation mass spectrometry.";
RL   Mol. Cell. Proteomics 8:904-912(2009).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44; SER-438 AND SER-468, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas,
RC   Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH FER1L5 AND MYOF.
RX   PubMed=21177873; DOI=10.1074/jbc.m110.157222;
RA   Posey A.D. Jr., Pytel P., Gardikiotes K., Demonbreun A.R., Rainey M.,
RA   George M., Band H., McNally E.M.;
RT   "Endocytic recycling proteins EHD1 and EHD2 interact with fer-1-like-5
RT   (Fer1L5) and mediate myoblast fusion.";
RL   J. Biol. Chem. 286:7379-7388(2011).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) IN COMPLEX WITH ATP ANALOG AND
RP   CALCIUM IONS, SUBUNIT, SUBCELLULAR LOCATION, ACTIVITY REGULATION, AND
RP   MUTAGENESIS OF THR-72; THR-94; ILE-157; ARG-167; PHE-322; LYS-324; LYS-327;
RP   LYS-328 AND LYS-329.
RX   PubMed=17914359; DOI=10.1038/nature06173;
RA   Daumke O., Lundmark R., Vallis Y., Martens S., Butler P.J.G., McMahon H.T.;
RT   "Architectural and mechanistic insights into an EHD ATPase involved in
RT   membrane remodelling.";
RL   Nature 449:923-927(2007).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 5-543 IN COMPLEX WITH ATP ANALOG
RP   AND CALCIUM IONS, FUNCTION, SUBCELLULAR LOCATION, MEMBRANE-BINDING, AND
RP   REGION.
RX   PubMed=24508342; DOI=10.1016/j.str.2013.12.015;
RA   Shah C., Hegde B.G., Moren B., Behrmann E., Mielke T., Moenke G.,
RA   Spahn C.M., Lundmark R., Daumke O., Langen R.;
RT   "Structural insights into membrane interaction and caveolar targeting of
RT   dynamin-like EHD2.";
RL   Structure 22:409-420(2014).
CC   -!- FUNCTION: ATP- and membrane-binding protein that controls membrane
CC       reorganization/tubulation upon ATP hydrolysis (PubMed:24508342). Plays
CC       a role in membrane trafficking between the plasma membrane and
CC       endosomes. Important for the internalization of GLUT4
CC       (PubMed:14676205). Required for fusion of myoblasts to skeletal muscle
CC       myotubes. Required for normal translocation of FER1L5 to the plasma
CC       membrane (PubMed:18502764, PubMed:21177873). Regulates the equilibrium
CC       between cell surface-associated and cell surface-dissociated caveolae
CC       by constraining caveolae at the cell membrane (By similarity).
CC       {ECO:0000250|UniProtKB:Q9NZN4, ECO:0000269|PubMed:14676205,
CC       ECO:0000269|PubMed:18502764, ECO:0000269|PubMed:21177873,
CC       ECO:0000269|PubMed:24508342}.
CC   -!- ACTIVITY REGULATION: The very low intrinsic ATPase activity is
CC       increased upon interaction with liposomes.
CC       {ECO:0000269|PubMed:17914359}.
CC   -!- SUBUNIT: Homodimer and homooligomer (By similarity). Interacts with
CC       EHD1 (By similarity). May also interact with EHD3 and EHD4 (By
CC       similarity). Interacts with MYOF (PubMed:18502764, PubMed:21177873).
CC       Interacts with EHBP1 (PubMed:14676205). Interacts with FER1L5 (via
CC       second C2 domain) (PubMed:21177873). Interacts with CAV1 in a
CC       cholesterol-dependent manner (By similarity). Interacts (via EH domain)
CC       with PACSIN2 (via NPF motifs); this interaction probably stablizes the
CC       caveolae (By similarity). {ECO:0000250|UniProtKB:Q9NZN4,
CC       ECO:0000269|PubMed:14676205, ECO:0000269|PubMed:17914359,
CC       ECO:0000269|PubMed:18502764, ECO:0000269|PubMed:21177873}.
CC   -!- INTERACTION:
CC       Q8BH64; Q8BH64: Ehd2; NbExp=6; IntAct=EBI-1994334, EBI-1994334;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:14676205};
CC       Peripheral membrane protein {ECO:0000269|PubMed:14676205}; Cytoplasmic
CC       side {ECO:0000269|PubMed:14676205}. Membrane, caveola
CC       {ECO:0000269|PubMed:24508342}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:24508342}; Cytoplasmic side
CC       {ECO:0000269|PubMed:24508342}. Endosome membrane
CC       {ECO:0000250|UniProtKB:Q4V8H8}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q4V8H8}; Cytoplasmic side
CC       {ECO:0000250|UniProtKB:Q4V8H8}. Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:14676205}. Note=Colocalizes with GLUT4 in
CC       intracellular tubulovesicular structures that are associated with
CC       cortical F-actin (PubMed:14676205). Colocalizes with FER1L5 at plasma
CC       membrane in myoblasts and myotubes (PubMed:18502764).
CC       {ECO:0000269|PubMed:14676205, ECO:0000269|PubMed:18502764}.
CC   -!- TISSUE SPECIFICITY: Detected in lung and adipocytes. Detected at lower
CC       levels in heart and skeletal muscle. {ECO:0000269|PubMed:14676205}.
CC   -!- DOMAIN: The EH domain interacts with Asn-Pro-Phe (NPF) motifs of target
CC       proteins. {ECO:0000269|PubMed:14676205}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class dynamin-like GTPase
CC       superfamily. Dynamin/Fzo/YdjA family. EHD subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU01055}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY531389; AAS48536.1; -; mRNA.
DR   EMBL; AK031203; BAC27298.1; -; mRNA.
DR   EMBL; AK046566; BAC32789.1; -; mRNA.
DR   EMBL; AK048356; BAC33310.1; -; mRNA.
DR   EMBL; AK050243; BAC34142.1; -; mRNA.
DR   EMBL; AK084455; BAC39188.1; -; mRNA.
DR   EMBL; AK085016; BAC39339.1; -; mRNA.
DR   EMBL; BC113161; AAI13162.1; -; mRNA.
DR   CCDS; CCDS20842.1; -.
DR   RefSeq; NP_694708.2; NM_153068.3.
DR   RefSeq; XP_011248884.1; XM_011250582.2.
DR   PDB; 2QPT; X-ray; 3.10 A; A=1-543.
DR   PDB; 4CID; X-ray; 3.00 A; A=5-543.
DR   PDBsum; 2QPT; -.
DR   PDBsum; 4CID; -.
DR   SMR; Q8BH64; -.
DR   BioGRID; 234420; 1.
DR   DIP; DIP-46806N; -.
DR   ELM; Q8BH64; -.
DR   IntAct; Q8BH64; 7.
DR   STRING; 10090.ENSMUSP00000096397; -.
DR   iPTMnet; Q8BH64; -.
DR   PhosphoSitePlus; Q8BH64; -.
DR   SwissPalm; Q8BH64; -.
DR   EPD; Q8BH64; -.
DR   jPOST; Q8BH64; -.
DR   MaxQB; Q8BH64; -.
DR   PaxDb; Q8BH64; -.
DR   PeptideAtlas; Q8BH64; -.
DR   PRIDE; Q8BH64; -.
DR   ProteomicsDB; 277566; -.
DR   Antibodypedia; 31594; 198 antibodies.
DR   Ensembl; ENSMUST00000098799; ENSMUSP00000096397; ENSMUSG00000074364.
DR   GeneID; 259300; -.
DR   KEGG; mmu:259300; -.
DR   UCSC; uc009fgt.1; mouse.
DR   CTD; 30846; -.
DR   MGI; MGI:2154274; Ehd2.
DR   eggNOG; KOG1954; Eukaryota.
DR   GeneTree; ENSGT00940000159256; -.
DR   HOGENOM; CLU_017595_1_1_1; -.
DR   InParanoid; Q8BH64; -.
DR   OMA; MQEQLMA; -.
DR   OrthoDB; 377342at2759; -.
DR   PhylomeDB; Q8BH64; -.
DR   TreeFam; TF314429; -.
DR   Reactome; R-MMU-983231; Factors involved in megakaryocyte development and platelet production.
DR   BioGRID-ORCS; 259300; 1 hit in 53 CRISPR screens.
DR   ChiTaRS; Ehd2; mouse.
DR   EvolutionaryTrace; Q8BH64; -.
DR   PRO; PR:Q8BH64; -.
DR   Proteomes; UP000000589; Chromosome 7.
DR   RNAct; Q8BH64; protein.
DR   Bgee; ENSMUSG00000074364; Expressed in epididymal fat pad and 245 other tissues.
DR   Genevisible; Q8BH64; MM.
DR   GO; GO:0005901; C:caveola; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005769; C:early endosome; IBA:GO_Central.
DR   GO; GO:0030139; C:endocytic vesicle; IBA:GO_Central.
DR   GO; GO:0019898; C:extrinsic component of membrane; IDA:UniProtKB.
DR   GO; GO:0045171; C:intercellular bridge; ISO:MGI.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IDA:MGI.
DR   GO; GO:0015630; C:microtubule cytoskeleton; ISO:MGI.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0055038; C:recycling endosome membrane; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005525; F:GTP binding; IEA:InterPro.
DR   GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0019904; F:protein domain specific binding; IDA:MGI.
DR   GO; GO:0060271; P:cilium assembly; IBA:GO_Central.
DR   GO; GO:0030866; P:cortical actin cytoskeleton organization; IDA:MGI.
DR   GO; GO:0032456; P:endocytic recycling; ISS:UniProtKB.
DR   GO; GO:0006897; P:endocytosis; IDA:MGI.
DR   GO; GO:0016197; P:endosomal transport; IBA:GO_Central.
DR   GO; GO:0097320; P:plasma membrane tubulation; IDA:UniProtKB.
DR   GO; GO:2001137; P:positive regulation of endocytic recycling; IMP:UniProtKB.
DR   GO; GO:1901741; P:positive regulation of myoblast fusion; IMP:UniProtKB.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IDA:UniProtKB.
DR   CDD; cd00052; EH; 1.
DR   DisProt; DP01940; -.
DR   InterPro; IPR040990; DUF5600.
DR   InterPro; IPR022812; Dynamin_SF.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR000261; EH_dom.
DR   InterPro; IPR029945; EHD2.
DR   InterPro; IPR031692; EHD_N.
DR   InterPro; IPR030381; G_DYNAMIN_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR11216:SF62; PTHR11216:SF62; 1.
DR   Pfam; PF18150; DUF5600; 1.
DR   Pfam; PF00350; Dynamin_N; 1.
DR   Pfam; PF12763; EF-hand_4; 1.
DR   Pfam; PF16880; EHD_N; 1.
DR   SMART; SM00027; EH; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS00018; EF_HAND_1; 1.
DR   PROSITE; PS50222; EF_HAND_2; 1.
DR   PROSITE; PS50031; EH; 1.
DR   PROSITE; PS51718; G_DYNAMIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Calcium; Cell membrane; Cytoplasm; Endosome;
KW   Hydrolase; Membrane; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..543
FT                   /note="EH domain-containing protein 2"
FT                   /id="PRO_0000322643"
FT   DOMAIN          55..286
FT                   /note="Dynamin-type G"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   DOMAIN          449..537
FT                   /note="EH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00077"
FT   DOMAIN          481..516
FT                   /note="EF-hand"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   NP_BIND         65..72
FT                   /note="ATP"
FT                   /evidence="ECO:0000269|PubMed:17914359,
FT                   ECO:0000269|PubMed:24508342, ECO:0007744|PDB:2QPT,
FT                   ECO:0007744|PDB:4CID"
FT   CA_BIND         494..505
FT                   /evidence="ECO:0000269|PubMed:17914359,
FT                   ECO:0000269|PubMed:24508342, ECO:0007744|PDB:2QPT,
FT                   ECO:0007744|PDB:4CID"
FT   REGION          65..72
FT                   /note="G1 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          91..92
FT                   /note="G2 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          153..156
FT                   /note="G3 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          219..222
FT                   /note="G4 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          243
FT                   /note="G5 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          320..340
FT                   /note="Mediates membrane-binding"
FT                   /evidence="ECO:0000269|PubMed:24508342"
FT   BINDING         220
FT                   /note="ATP"
FT                   /evidence="ECO:0000269|PubMed:24508342,
FT                   ECO:0007744|PDB:4CID"
FT   BINDING         258
FT                   /note="ATP"
FT                   /evidence="ECO:0000269|PubMed:17914359,
FT                   ECO:0000269|PubMed:24508342, ECO:0007744|PDB:2QPT,
FT                   ECO:0007744|PDB:4CID"
FT   MOD_RES         3
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q4V8H8"
FT   MOD_RES         44
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         438
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:15345747,
FT                   ECO:0007744|PubMed:19131326, ECO:0007744|PubMed:21183079"
FT   MOD_RES         468
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         470
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZN4"
FT   MOD_RES         484
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZN4"
FT   MOD_RES         493
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q4V8H8"
FT   MUTAGEN         65
FT                   /note="G->R: Inhibits myoblast fusion."
FT                   /evidence="ECO:0000269|PubMed:18502764"
FT   MUTAGEN         72
FT                   /note="T->A: Abolishes ATP binding."
FT                   /evidence="ECO:0000269|PubMed:17914359"
FT   MUTAGEN         94
FT                   /note="T->A: Abolishes increase of intrinsic ATPase
FT                   activity upon interaction with membranes."
FT                   /evidence="ECO:0000269|PubMed:17914359"
FT   MUTAGEN         157
FT                   /note="I->Q: Increases intrinsic ATPase activity."
FT                   /evidence="ECO:0000269|PubMed:17914359"
FT   MUTAGEN         167
FT                   /note="R->E: Increases intrinsic ATPase activity."
FT                   /evidence="ECO:0000269|PubMed:17914359"
FT   MUTAGEN         322
FT                   /note="F->A: Abolishes localization at the plasma membrane;
FT                   reduces increase of intrinsic ATPase activity upon
FT                   interaction with membranes."
FT                   /evidence="ECO:0000269|PubMed:17914359"
FT   MUTAGEN         324
FT                   /note="K->D: Abolishes localization at the plasma
FT                   membrane."
FT                   /evidence="ECO:0000269|PubMed:17914359"
FT   MUTAGEN         327
FT                   /note="K->D: Abolishes localization at the plasma membrane;
FT                   abolishes increase of intrinsic ATPase activity upon
FT                   interaction with membranes."
FT                   /evidence="ECO:0000269|PubMed:17914359"
FT   MUTAGEN         328
FT                   /note="K->D: Abolishes localization at the plasma membrane;
FT                   reduces increase of intrinsic ATPase activity upon
FT                   interaction with membranes."
FT                   /evidence="ECO:0000269|PubMed:17914359"
FT   MUTAGEN         329
FT                   /note="K->D: Abolishes localization at the plasma
FT                   membrane."
FT                   /evidence="ECO:0000269|PubMed:17914359"
FT   CONFLICT        181
FT                   /note="R -> S (in Ref. 2; BAC32789)"
FT                   /evidence="ECO:0000305"
FT   HELIX           21..32
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           34..39
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           42..44
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           52..56
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   STRAND          60..66
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           71..79
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   STRAND          96..102
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   STRAND          104..109
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   STRAND          134..141
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           145..147
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   STRAND          150..153
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           171..181
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   STRAND          183..190
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           191..193
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           198..207
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           211..213
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   STRAND          214..219
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   TURN            220..223
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           226..244
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   STRAND          252..255
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   STRAND          258..260
FT                   /evidence="ECO:0007744|PDB:2QPT"
FT   HELIX           268..283
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   TURN            284..288
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           289..317
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   STRAND          320..323
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           324..346
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           350..352
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           356..364
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           368..370
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           376..387
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           389..403
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           405..407
FT                   /evidence="ECO:0007744|PDB:2QPT"
FT   STRAND          411..414
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           416..419
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           447..459
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   STRAND          466..468
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           469..476
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           477..479
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           483..493
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   STRAND          498..502
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           503..518
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           528..530
FT                   /evidence="ECO:0007744|PDB:4CID"
FT   HELIX           533..535
FT                   /evidence="ECO:0007744|PDB:4CID"
SQ   SEQUENCE   543 AA;  61174 MW;  47637795B0B1096E CRC64;
     MFSWLKKGGA RGQRPEAIRT VTSSLKELYR TKLLPLEEHY RFGSFHSPAL EDADFDGKPM
     VLVAGQYSTG KTSFIQYLLE QEVPGSRVGP EPTTDCFVAV MHGETEGTVP GNALVVDPEK
     PFRKLNPFGN TFLNRFMCAQ LPNQVLESIS IIDTPGILSG AKQRVSRGYD FPAVLRWFAE
     RVDLIILLFD AHKLEISDEF SEAIGALRGH EDKIRVVLNK ADMVETQQLM RVYGALMWAL
     GKVVGTPEVL RVYIGSFWSQ PLLVPDNRRL FELEEQDLFR DIQGLPRHAA LRKLNDLVKR
     ARLVRVHAYI ISYLKKEMPT VFGKENKKKQ LILKLPVIFA KIQLEHHISP GDFPDCQKMQ
     ELLMAHDFTK FHSLKPKLLE ALDDMLAQDI AKLMPLLRQE ELESVEAGVQ GGAFEGTRMG
     PFVERGPDEA IEDGEEGSED DAEWVVTKDK SKYDEIFYNL APADGKLSGS KAKTWMVGTK
     LPNSVLGRIW KLSDVDRDGM LDDEEFALAS HLIEAKLEGH GLPTNLPRRL VPPSKRRQKG
     SAE
//
